ABVC BioPharma, Inc. (NASDAQ:ABVC – Get Free Report) was the recipient of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 124,000 shares, a decrease of 6.3% from the January 15th total of 132,400 shares. Based on an average daily volume of 2,470,000 shares, […]
FREMONT, CA, Feb. 15, 2024 (GLOBE NEWSWIRE) via NewMediaWire ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it signed a definitive agreement to license certain of its healthcare-related expertise ("Know-How") to Senior Paradise, Inc. ("SPI"), who will also lease certain of the Company's properties (the "Land") for further development relat
Shares of ABVC BioPharma, Inc. (ABVC) surged over 230% on Thursday morning after the clinical-stage biopharmaceutical company inked a licensing agreement with AiBtl BioPharma for its CNS drugs.
ABVC BioPharma, Inc. (NASDAQ:ABVC – Get Free Report) was the target of a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 14,100 shares, a drop of 26.9% from the September 15th total of 19,300 shares. Approximately 0.6% of the company’s stock are short sold. […]